Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Growth Hormone Treatment in Short Children Born Small for Gestational Age Based on a Growth Prediction Model-The OPTIMA Trial

NCT00191529 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00191529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00191529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Growth Hormone Treatment in Short Children Born Small for Gestational Age Based on a Growth Prediction Model-The OPTIMA Trial
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
June 30, 2007
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infant, small for gestational age